Trial Profile
The effect of tofacitinib on the activity of JAK-STAT pathways in patients with rheumatoid arthritis (RA)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Nov 2021
Price :
$35
*
At a glance
- Drugs Tofacitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 26 Nov 2021 Status changed from recruiting to completed.
- 07 Jun 2018 New trial record